Deep Track Capital
Overview
Deep Track Capital is a Greenwich, Connecticut-based investment firm focused exclusively on the life sciences industry. They develop long-term partnerships with management teams of leading innovative public and pre-IPO biotechnology companies. In addition to capital, they seek to invest their time and expertise, while leveraging their network for the benefit of their partners. They aim to lead transactions while building large syndicates and also invest in rounds led by other qualified investors. In 2024, Deep Track Capital participated in six funding rounds across various stages, including Seed, PIPE, and Series A-D. Notable additions to its portfolio include enGene, Jade Biosciences, TORL BioTherapeutics, and MBX Biosciences. The firm’s largest single investment was a $555 million PIPE funding in Bicycle Therapeutics. Their investment approach is fundamentally driven, aiming to capitalize on the varied outcomes within biotech development. They focus on therapeutic areas such as oncology, infectious diseases, neurology, immunology, ophthalmology, hepatology, dermatology, and cardiology, and technological focuses including antibodies, small molecules, cell and gene therapies, immunotherapies, peptides, antibody conjugates, and ophthalmic devices.
Investment Focus
- Focus on life sciences industry
- Preference for public and pre-IPO biotechnology companies
- Interest in both equity and debt instruments
- Willingness to lead transactions and build large syndicates
- Open to investing in rounds led by other qualified investors
Portfolio Companies
Reach Deep Track Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Deep Track Capital
What sectors does Deep Track Capital invest in?
Deep Track Capital invests in Medical Devices, Diagnostics, Biotechnology, Specialty Pharmaceuticals and Life Sciences Tools and Services, and is based in Connecticut, United States. Deep Track Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Deep Track Capital invest at?
Deep Track Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 10M - 500M.
Which regions does Deep Track Capital invest in?
Deep Track Capital invests across United States.
What companies has Deep Track Capital invested in?
Deep Track Capital's portfolio includes Attovia Therapeutics, Maze Therapeutics, Obsidian Therapeutics, Latigo Biotherapeutics, Tubulis, Arbor Biotechnologies, enGene and Jade Biosciences.
Last updated · Source: ConnectSafely investor database
